US Pharmacopeia (USP) published Chapter 825 and made the guidelines final as of Dec, 31, 2020. This presentation will discuss the history, components and risk levels of USP <825>. The USP Chapter <825> guidelines for commercial nuclear pharmacies will be presented with practical application approach and details of the changes affecting nuclear medicine departments will be discussed. You will learn how to apply USP <825> standards to your daily radiopharmacy practice.
CREDITS: 1.00 CEHs (Continuing Education Hours)